| 孙兴奎.氨溴索辅佐阿奇霉素治疗肺炎支原体疗效评价探讨[J].实用中西医结合临床,2016,16(9): |
| 氨溴索辅佐阿奇霉素治疗肺炎支原体疗效评价探讨 |
| To Evaluate the Curative Effect of Azithromycin Assisted by Ambroxol in the Treatment of Mycoplasma Pneumonia |
| 投稿时间：2016-09-01 修订日期：2016-09-10 |
| DOI： |
| 中文关键词: 支原体肺炎 氨溴索 阿奇霉素 临床疗效 评价 |
| 英文关键词: Mycoplasma pneumonia Ambroxol Azithromycin Clinical curative effect Evaluate |
| 基金项目: |
|
| 摘要点击次数: 682 |
| 全文下载次数: 371 |
| 中文摘要: |
| 目的：评价氨溴索辅佐阿奇霉素治疗支原体肺炎患儿的临床疗效。方法：选取我院2015年5月至2016年5月收治的67例支原体肺炎患儿，分为观察组和参照组，给予参照组患儿阿奇霉素治疗，给予观察组患儿氨溴索辅佐阿奇霉素治疗。结果：观察组患儿咳嗽、发热、肺部啰音的开始缓解时间均较参照组患儿早（P均<0.05），临床治疗总有效率为94.1%，高于参照组患儿的72.7%（P<0.05），住院时间为（7.8±2.1）d，短于参照组患儿的（10.7±2.3）d（P<0.05），两组患儿均未发生严重不良反应（P>0.05）。结论：应用氨溴索辅佐阿奇霉素治疗支原体肺炎，药效发挥迅速，效果确切，安全性高，具有临床推广应用价值。 |
| 英文摘要: |
| Objective: To evaluate the clinical efficacy of azithromycin assisted by ambroxol in the treatment of children with Mycoplasma pneumonia. Methods: 67 cases of children with mycoplasma pneumonia from May 2015 to May 2016 in our hospital were divided into the observation group and the reference group. Arranging the treatment of azithromycin to the reference group, while the treatment of Azithromycin assisted by ambroxol to the observation group. Results: The observation group with symptoms of cough, fever, and pulmonary rales, was remitted early in disease median response time comparing with the reference group (P<0.05). Its total effective rate in clinical treatment was 94.1%, which higher than the reference group with 72.7% (P<0.05). And the length of stay of the observation group was(7.8±2.1)d, which shorter than the reference group (10.7±2.3) d (P<0.05). Serious adverse reaction did not occur in children of these two groups (P>0.05). Conclusions: Applying azithromycin assisted by ambroxol of mycoplasma pneumonia for it can catch pesticide effect rapidly, effectively, and safely, which has the value of clinical application. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
